Výsledky vyhledávání - "L. Becker Hewes"

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

Autor: H. Jean Khoury, L. Becker Hewes, Jonathan L. Kaufman, Sagar Lonial, Christopher R. Flowers, Julie M. Vose, Amelia Langston, Gary B. Calandra, Mary Jo Lechowicz, Edmund K. Waller, Karen D. Rados

Publikováno v: Transfusion. 53:76-84

BACKGROUND: Previous reports suggested that rituximab may impair stem cell collection and posttransplant engraftment in lymphoma patients undergoing autologous hematopoietic progenitor cell transplantation. STUDY DESIGN AND METHODS: A prospective bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::24d6954457197bf39c79756a8f074184
https://doi.org/10.1111/j.1537-2995.2012.03719.x

Zobrazit plný text záznamu

Anti-CD137 Antibodies in the Treatment of Autoimmune Disease and Cancer

Autor: L. Becker Hewes, Abhijit Bapat, Liguo Niu, Juergen Foell, Simona Strahotin, Robert S. Mittler, Megan McCausland

Publikováno v: Immunologic Research. 29:197-208

CD137 (4-1BB), is an inducible T-cell costimulatory receptor and a member of the tumor necrosis factor receptor (TNFR) superfamily. It is expressed on activated T cells and activated natural killer (NK) cells, but is constitutively expressed on a pop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8beeffc3fbc5c02260608085cd5cc479
https://doi.org/10.1385/ir:29:1-3:197

Zobrazit plný text záznamu

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

Autor: Jonathan L, Kaufman, Christopher R, Flowers, Karen D, Rados, Gary B, Calandra, Julie M, Vose, L Becker, Hewes, Sagar, Lonial, Amelia A, Langston, H Jean, Khoury, Mary Jo, Lechowicz, Edmund K, Waller

Publikováno v: Transfusion. 53(1)

Previous reports suggested that rituximab may impair stem cell collection and posttransplant engraftment in lymphoma patients undergoing autologous hematopoietic progenitor cell transplantation.A prospective biologic allocation study examined the eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8c8bb9592f8220b83de4e65fc241a28d
https://pubmed.ncbi.nlm.nih.gov/22624594

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání